Renal Impact of KAFTRIO in Mucoviscidose Population

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Cystic Fibrosis
Interventions
BIOLOGICAL

Evaluation of the parameters of the lithiasis assessment before and after KAFTRIO initiation

Collection of Uricuria, phosphaturie, calciuria, magnesuria, glycosuria, citraturia, oxaluria, before and after initiation of KAFTRIO

DRUG

Collection of Arterial pressure, metabolic data, kidney function, proteinuria and hematuria before and after KATRIO initiation

Arterial pressure, glycemia, glycated hemoglobin, lipid profile, weight, serum and urinary electrolytes, hepatic check, complete blood count, calcium phosphate balance and urinary sediment analysis before and after initiation of KAFTRIO

Trial Locations (1)

69310

RECRUITING

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER